首页 > 最新文献

Plastic Surgery最新文献

英文 中文
Catheter use and infection reduction in plastic surgery. 整形手术中导管的使用和感染的减少。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01 DOI: 10.1177/229255031302100205
Zach J Barnes, Raman C Mahabir

Background: Catheter-associated urinary tract infections (CAUTI) are the most common hospital-associated infection and can result in increased health care costs, morbidity and even mortality. In 2009, The Scott & White Memorial Hospital/Texas A&M Health Science Center (Texas, USA) system's CAUTI rate placed it in the upper quartile (ie, highest rate) for the country, necessitating a system-wide change.

Objective: To design and implement a guideline to reduce the incidence of CAUTI.

Methods: A multidisciplinary team was formed and completed both a root cause analysis and a review of the available literature. Consolidating the best evidence, the team formulated a best practice guideline detailing the proper indications for insertion of, improper use of and techniques to minimize infection with catheters. Included as part of this protocol was nursing and patient education, changes in identifying patients with a catheter and automatic termination orders. Three-, six- and 12-month reviews identifying additional opportunities for improvement at the end of 2010 were completed.

Results: In 2009, the hospital's CAUTI rate was 1.46 per 1000 catheter days. In 2011 - the first complete year of the finalized guideline - the hospital's CAUTI rate was 0.52 per 1000 catheter days, ranking the institution in the bottom quartile (ie, lowest rate) for the country. The surgery and plastic surgery subgroup analyses also demonstrated statistically significant reduction in both catheter use and CAUTI.

Conclusion: The incidence of CAUTI was successfully reduced at The Texas A&M Healthcare Center. The guideline, its development and how it applies to plastic surgery patients are discussed.

背景:导尿管相关性尿路感染(CAUTI)是最常见的医院相关感染,可导致医疗费用、发病率甚至死亡率增加。2009年,Scott & White纪念医院/Texas A&M Health Science Center (Texas, USA)系统的CAUTI比率在全国名列前茅(即最高比率),因此需要进行全系统的改革。目的:设计并实施降低CAUTI发生率的指南。方法:组成了一个多学科小组,完成了根本原因分析和对现有文献的回顾。为了巩固最佳证据,该团队制定了最佳实践指南,详细说明了导管插入的适当适应症、不当使用和技术,以尽量减少导管感染。作为该方案的一部分,包括护理和患者教育,识别导管患者的变化和自动终止命令。在2010年底完成了3个月、6个月和12个月的审查,确定了进一步改进的机会。结果:2009年该院CAUTI率为1.46 / 1000导管d。2011年,即指南最终定稿的第一年,该医院的CAUTI率为每1000个导管日0.52例,在全国排名垫底四分之一(即最低率)。手术和整形手术亚组分析也显示导管使用和CAUTI的统计学显著减少。结论:得克萨斯A&M医疗中心成功降低了CAUTI的发病率。本文讨论了该指南的发展及其在整形手术患者中的应用。
{"title":"Catheter use and infection reduction in plastic surgery.","authors":"Zach J Barnes,&nbsp;Raman C Mahabir","doi":"10.1177/229255031302100205","DOIUrl":"https://doi.org/10.1177/229255031302100205","url":null,"abstract":"<p><strong>Background: </strong>Catheter-associated urinary tract infections (CAUTI) are the most common hospital-associated infection and can result in increased health care costs, morbidity and even mortality. In 2009, The Scott & White Memorial Hospital/Texas A&M Health Science Center (Texas, USA) system's CAUTI rate placed it in the upper quartile (ie, highest rate) for the country, necessitating a system-wide change.</p><p><strong>Objective: </strong>To design and implement a guideline to reduce the incidence of CAUTI.</p><p><strong>Methods: </strong>A multidisciplinary team was formed and completed both a root cause analysis and a review of the available literature. Consolidating the best evidence, the team formulated a best practice guideline detailing the proper indications for insertion of, improper use of and techniques to minimize infection with catheters. Included as part of this protocol was nursing and patient education, changes in identifying patients with a catheter and automatic termination orders. Three-, six- and 12-month reviews identifying additional opportunities for improvement at the end of 2010 were completed.</p><p><strong>Results: </strong>In 2009, the hospital's CAUTI rate was 1.46 per 1000 catheter days. In 2011 - the first complete year of the finalized guideline - the hospital's CAUTI rate was 0.52 per 1000 catheter days, ranking the institution in the bottom quartile (ie, lowest rate) for the country. The surgery and plastic surgery subgroup analyses also demonstrated statistically significant reduction in both catheter use and CAUTI.</p><p><strong>Conclusion: </strong>The incidence of CAUTI was successfully reduced at The Texas A&M Healthcare Center. The guideline, its development and how it applies to plastic surgery patients are discussed.</p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/229255031302100205","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32037042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Effect of sildenafil citrate in nicotine-induced ischemia: An experimental study using a rat model. 枸橼酸西地那非对尼古丁诱导的大鼠缺血作用的实验研究。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01
Halit Baykan, Irfan Ozyazgan, Caferi Tayyar Selçuk, Mehmet Altiparmak, Mehmet Ozköse, Kemal Ozyurt

Recent experimental and clinical studies have demonstrated the negative effects of nicotine on the viability of skin flaps. Necrotic damage to skin flaps can result in significant complications including delayed wound healing, dehiscence and wound contraction. Phosphodiesterase type 5 inhibitors, such as sildenafil citrate, have a protective effect in ischemic injuries of the brain, kidney, myocardium, spinal cord, ileum and testes. In the present study, the authors evaluated the effect of sildenafil citrate on the viability of skin exposed to nicotine-induced ischemia in Sprague Dawley rats. In the preoperative period, the rats were divided into three groups of 10 rats each. Group C was treated with subcutaneous saline and group S and group N were treated with 2 mg/kg nicotine, administered subcutaneously twice per day for 28 days. McFarlane flaps were created in all experimental animals using an incision measuring 7 cm × 3 cm. Postoperative treatment varied among the groups: group S was treated with 20 mg/kg/day sildenafil citrate, while group C and group N were treated with equivalent doses of saline for seven days. A laser Doppler flow meter was used to monitor the microvasculature. Preoperative measurements of the microvasculature revealed decreased blood flow in group N and group S, both of which were treated with subcutaneous nicotine. During the postoperative evaluation, a trend toward increased blood flow was observed in group S compared with the group with nicotine-induced ischemia treated with saline alone postoperatively (group N). A visual fluorescein dye test was used to predict skin viability and demonstrated diminished skin viability in group N and group S (P<0.05) during the preoperative period. Following treatment with sildenafil for seven days, a statically significant improvement in skin viability was observed in group S (P<0.05). Nicotine decreased blood flow within the skin and impaired skin viability, while postoperative application of sildenafil significantly ameliorated the ischemic effects of nicotine and improved skin viability. Future studies will be required to evaluate the clinical use of sildenafil for the improvement of blood flow in ischemic injury of the skin.

最近的实验和临床研究已经证明了尼古丁对皮瓣生存能力的负面影响。皮瓣的坏死损伤可导致严重的并发症,包括伤口愈合延迟、裂开和伤口收缩。磷酸二酯酶5型抑制剂,如柠檬酸西地那非,对脑、肾、心肌、脊髓、回肠和睾丸的缺血性损伤有保护作用。在本研究中,作者评估了枸橼酸西地那非对暴露于尼古丁诱导的大鼠皮肤缺血的影响。术前将大鼠分为三组,每组10只大鼠。C组皮下注射生理盐水,S组和N组皮下注射2 mg/kg尼古丁,每天2次,连用28 d。在所有实验动物中使用7厘米× 3厘米的切口制作麦克法兰皮瓣。术后各组治疗方法不同:S组给予枸橼酸西地那非20 mg/kg/d, C组和N组给予等量生理盐水,疗程7 d。采用激光多普勒血流仪监测微血管。术前微血管测量显示N组和S组的血流量减少,这两组都接受了皮下尼古丁治疗。在术后评估中,与术后仅用生理盐水处理尼古丁引起的缺血组(N组)相比,S组的血流量有增加的趋势。用视觉荧光素染色试验预测皮肤活力,结果显示N组和S组的皮肤活力下降(P
{"title":"Effect of sildenafil citrate in nicotine-induced ischemia: An experimental study using a rat model.","authors":"Halit Baykan,&nbsp;Irfan Ozyazgan,&nbsp;Caferi Tayyar Selçuk,&nbsp;Mehmet Altiparmak,&nbsp;Mehmet Ozköse,&nbsp;Kemal Ozyurt","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Recent experimental and clinical studies have demonstrated the negative effects of nicotine on the viability of skin flaps. Necrotic damage to skin flaps can result in significant complications including delayed wound healing, dehiscence and wound contraction. Phosphodiesterase type 5 inhibitors, such as sildenafil citrate, have a protective effect in ischemic injuries of the brain, kidney, myocardium, spinal cord, ileum and testes. In the present study, the authors evaluated the effect of sildenafil citrate on the viability of skin exposed to nicotine-induced ischemia in Sprague Dawley rats. In the preoperative period, the rats were divided into three groups of 10 rats each. Group C was treated with subcutaneous saline and group S and group N were treated with 2 mg/kg nicotine, administered subcutaneously twice per day for 28 days. McFarlane flaps were created in all experimental animals using an incision measuring 7 cm × 3 cm. Postoperative treatment varied among the groups: group S was treated with 20 mg/kg/day sildenafil citrate, while group C and group N were treated with equivalent doses of saline for seven days. A laser Doppler flow meter was used to monitor the microvasculature. Preoperative measurements of the microvasculature revealed decreased blood flow in group N and group S, both of which were treated with subcutaneous nicotine. During the postoperative evaluation, a trend toward increased blood flow was observed in group S compared with the group with nicotine-induced ischemia treated with saline alone postoperatively (group N). A visual fluorescein dye test was used to predict skin viability and demonstrated diminished skin viability in group N and group S (P<0.05) during the preoperative period. Following treatment with sildenafil for seven days, a statically significant improvement in skin viability was observed in group S (P<0.05). Nicotine decreased blood flow within the skin and impaired skin viability, while postoperative application of sildenafil significantly ameliorated the ischemic effects of nicotine and improved skin viability. Future studies will be required to evaluate the clinical use of sildenafil for the improvement of blood flow in ischemic injury of the skin. </p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910519/pdf/cjps21217.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32090337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pyoderma gangrenosum: A case report of bilateral dorsal hand lesions and literature review of management. 坏疽性脓皮病:双侧手背病变1例及治疗文献复习。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01
Donald S Mowlds, Jeff J Kim, Patrick Murphy, Garrett A Wirth

Pyoderma gangrenosum is a great masquerader in wound diagnosis and management. Frequently misdiagnosed as a necrotizing infection, the elusive nature of its etiology and pathogenesis has thwarted the establishment of a standardized management algorithm, leaving immunosuppressant therapies as the mainstay of treatment. The present report describes a 61-year-old woman presenting with temporally discrete bilateral dorsal hand lesions successfully managed with distinctive multimodality therapies. The initial lesion was managed under the auspices of a necrotizing process using a combination of hyperbaric oxygen therapy and skin grafting with a negative-pressure dressing, both individually demonstrated to be effective for prompt wound stabilization and coverage. A subsequent contralateral hand lesion was similarly managed as a necrotizing infection before a diagnosis of pyoderma gangrenosum was considered. Stabilization and eventual resolution was achieved using intravenous and topical steroids followed by hyperbaric oxygen therapy, again highlighting the benefits of multimodality therapy in the setting of pyoderma gangrenosum.

坏疽性脓皮病是创伤诊断和治疗中的一大难题。经常被误诊为坏死性感染,其病因和发病机制难以捉摸的性质阻碍了标准化管理算法的建立,使免疫抑制疗法成为治疗的主要手段。本报告描述了一名61岁的女性,表现为时间离散的双侧手背病变,通过独特的多模式治疗成功管理。最初的病变是在坏死性过程的支持下处理的,使用高压氧治疗和带负压敷料的皮肤移植相结合,这两种方法都被单独证明对迅速稳定和覆盖伤口是有效的。随后的对侧手部病变同样作为坏死性感染处理,然后才考虑诊断为坏疽性脓皮病。通过静脉注射和局部类固醇,再加上高压氧治疗,稳定和最终解决了问题,再次强调了多模式治疗坏疽性脓皮病的好处。
{"title":"Pyoderma gangrenosum: A case report of bilateral dorsal hand lesions and literature review of management.","authors":"Donald S Mowlds,&nbsp;Jeff J Kim,&nbsp;Patrick Murphy,&nbsp;Garrett A Wirth","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pyoderma gangrenosum is a great masquerader in wound diagnosis and management. Frequently misdiagnosed as a necrotizing infection, the elusive nature of its etiology and pathogenesis has thwarted the establishment of a standardized management algorithm, leaving immunosuppressant therapies as the mainstay of treatment. The present report describes a 61-year-old woman presenting with temporally discrete bilateral dorsal hand lesions successfully managed with distinctive multimodality therapies. The initial lesion was managed under the auspices of a necrotizing process using a combination of hyperbaric oxygen therapy and skin grafting with a negative-pressure dressing, both individually demonstrated to be effective for prompt wound stabilization and coverage. A subsequent contralateral hand lesion was similarly managed as a necrotizing infection before a diagnosis of pyoderma gangrenosum was considered. Stabilization and eventual resolution was achieved using intravenous and topical steroids followed by hyperbaric oxygen therapy, again highlighting the benefits of multimodality therapy in the setting of pyoderma gangrenosum. </p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910530/pdf/cjps21239.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32090571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral exam. 口语考试。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01
{"title":"Oral exam.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910520/pdf/cjps21249.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32090574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost: It's all in the eye of the beholder. 代价:一切都在旁观者的眼中。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01
Douglas R McKay, Daniel A Peters
{"title":"Cost: It's all in the eye of the beholder.","authors":"Douglas R McKay,&nbsp;Daniel A Peters","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910529/pdf/cjps21251.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32090575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin. 瘢痕疙瘩的根除:手术切除,病灶内单次注射5-氟尿嘧啶和肉毒毒素。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01 DOI: 10.1177/229255031302100208
Adel Michel Wilson

Background: Keloids may complicate wound healing secondary to trauma, inflammation or surgical incision. Although various treatment modalities have been used with variable degrees of success, overall recurrence rates have remained unacceptably high.

Methods: The present study involved 80 patients with keloids of at least one-years' duration. Following total surgical excision of the keloid, a single dose of 5-fluorouracil was injected into the edges of the healing wound on postoperative day 9 together with botulinum toxin. The concentration of 5-fluorouracil used was 50 mg/mL and approximately 0.4 mL was infiltrated per cm of wound tissue, with the total dose <500 mg. The concentration of botulinum toxin was 50 IU/mL with the total dose <140 IU.

Results: Patients were followed-up for 17 to 24 months and a recurrence rate of 3.75% was found, which was significantly lower than in previously reported studies using other therapeutic modalities.

Conclusion: The author recommends that this treatment be routinely applied to all keloids because it is significantly more effective than those described by other authors.

背景:瘢痕疙瘩可使继发于创伤、炎症或手术切口的伤口愈合复杂化。尽管使用了各种治疗方法,取得了不同程度的成功,但总体复发率仍然高得令人无法接受。方法:本研究纳入80例持续时间至少1年的瘢痕疙瘩患者。手术切除瘢痕瘤后,术后第9天将单剂量的5-氟尿嘧啶与肉毒杆菌毒素一起注射到愈合伤口的边缘。5-氟尿嘧啶使用浓度为50 mg/mL,每cm创面组织浸润约0.4 mL,总剂量结果:患者随访17 ~ 24个月,复发率为3.75%,明显低于既往报道的使用其他治疗方式的研究。结论:作者建议将这种治疗常规应用于所有瘢痕疙瘩,因为它明显比其他作者所描述的更有效。
{"title":"Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin.","authors":"Adel Michel Wilson","doi":"10.1177/229255031302100208","DOIUrl":"10.1177/229255031302100208","url":null,"abstract":"<p><strong>Background: </strong>Keloids may complicate wound healing secondary to trauma, inflammation or surgical incision. Although various treatment modalities have been used with variable degrees of success, overall recurrence rates have remained unacceptably high.</p><p><strong>Methods: </strong>The present study involved 80 patients with keloids of at least one-years' duration. Following total surgical excision of the keloid, a single dose of 5-fluorouracil was injected into the edges of the healing wound on postoperative day 9 together with botulinum toxin. The concentration of 5-fluorouracil used was 50 mg/mL and approximately 0.4 mL was infiltrated per cm of wound tissue, with the total dose <500 mg. The concentration of botulinum toxin was 50 IU/mL with the total dose <140 IU.</p><p><strong>Results: </strong>Patients were followed-up for 17 to 24 months and a recurrence rate of 3.75% was found, which was significantly lower than in previously reported studies using other therapeutic modalities.</p><p><strong>Conclusion: </strong>The author recommends that this treatment be routinely applied to all keloids because it is significantly more effective than those described by other authors.</p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/229255031302100208","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32037044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Breast reduction surgery in Ontario: Changes in practice, 1992 to 2008. 安大略省的缩胸手术:1992年至2008年的实践变化。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01 DOI: 10.1177/229255031302100104
Bisher Alshanawani, Nawarah Alarfaj, Feras Alshomer, Muhammad Mamdani, Tara Gomes, James Mahoney

Background: Symptomatic mammary hypertrophy impacts physical function and patient quality of life. Breast reduction mammoplasty, a surgical procedure performed to reduce breast size, has been used for many years to reduce these symptoms.

Objective: To evaluate variations in the surgical practice of breast reduction mammoplasty among women ≥15 years of age (approximately 6.4 million population in 2008) over a 17-year period in Ontario.

Method: A population-based, cross-sectional time series analysis was conducted to examine temporal trends in 87,049 breast reduction surgeries performed between January 1, 1992 and December 30, 2008.

Results: Breast reduction rates have been relatively stable over time, with 83 per 100,000 of the female population undergoing breast reduction surgery annually. However, a significant decrease in the rate of inpatient surgeries were observed over the study period (from 69.3 per 100,000 in 1992 to 25.7 per 100,000 in 2008). At the beginning of the study period, the highest annual rates of this procedure were observed among women 21 to 30 years of age (116.6 procedures per 100,000); however, by the end of the observation period, this shifted to women 31 to 50 years of age (109.9 procedures per 100,000). Furthermore, the annual procedure rate among women ≥51 years of age almost doubled, rising from 36.4 procedures per 100,000 in 1992 to 66.6 procedures per 100,000 in 2008. This was likely related to changing demographics and social factors.

Conclusion: These data suggest that breast reduction mammoplasty will continue to be requested, with an increased proportion of patients who are older and desire improved quality of life and physical function.

背景:症状性乳腺肥大影响身体功能和患者生活质量。缩乳术是一种缩小乳房大小的外科手术,多年来一直用于减轻这些症状。目的:评估安大略省17年来≥15岁妇女(2008年约640万人口)缩乳手术实践的变化。方法:对1992年1月1日至2008年12月30日期间进行的87,049例缩胸手术的时间趋势进行了以人群为基础的横断面时间序列分析。结果:随着时间的推移,乳房缩小率相对稳定,每年每10万女性人口中有83人接受乳房缩小手术。然而,在研究期间,住院手术率显著下降(从1992年的69.3 / 10万下降到2008年的25.7 / 10万)。在研究期开始时,在21至30岁的妇女中观察到这种手术的年发病率最高(每10万人中有116.6例);然而,在观察期结束时,这一情况转变为31至50岁的妇女(每10万人中有109.9例手术)。此外,51岁以上妇女的年手术率几乎翻了一番,从1992年的每10万人36.4例上升到2008年的每10万人66.6例。这可能与人口结构和社会因素的变化有关。结论:这些数据表明,随着年龄的增加,希望改善生活质量和身体功能的患者比例增加,将继续要求缩乳。
{"title":"Breast reduction surgery in Ontario: Changes in practice, 1992 to 2008.","authors":"Bisher Alshanawani,&nbsp;Nawarah Alarfaj,&nbsp;Feras Alshomer,&nbsp;Muhammad Mamdani,&nbsp;Tara Gomes,&nbsp;James Mahoney","doi":"10.1177/229255031302100104","DOIUrl":"https://doi.org/10.1177/229255031302100104","url":null,"abstract":"<p><strong>Background: </strong>Symptomatic mammary hypertrophy impacts physical function and patient quality of life. Breast reduction mammoplasty, a surgical procedure performed to reduce breast size, has been used for many years to reduce these symptoms.</p><p><strong>Objective: </strong>To evaluate variations in the surgical practice of breast reduction mammoplasty among women ≥15 years of age (approximately 6.4 million population in 2008) over a 17-year period in Ontario.</p><p><strong>Method: </strong>A population-based, cross-sectional time series analysis was conducted to examine temporal trends in 87,049 breast reduction surgeries performed between January 1, 1992 and December 30, 2008.</p><p><strong>Results: </strong>Breast reduction rates have been relatively stable over time, with 83 per 100,000 of the female population undergoing breast reduction surgery annually. However, a significant decrease in the rate of inpatient surgeries were observed over the study period (from 69.3 per 100,000 in 1992 to 25.7 per 100,000 in 2008). At the beginning of the study period, the highest annual rates of this procedure were observed among women 21 to 30 years of age (116.6 procedures per 100,000); however, by the end of the observation period, this shifted to women 31 to 50 years of age (109.9 procedures per 100,000). Furthermore, the annual procedure rate among women ≥51 years of age almost doubled, rising from 36.4 procedures per 100,000 in 1992 to 66.6 procedures per 100,000 in 2008. This was likely related to changing demographics and social factors.</p><p><strong>Conclusion: </strong>These data suggest that breast reduction mammoplasty will continue to be requested, with an increased proportion of patients who are older and desire improved quality of life and physical function.</p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/229255031302100104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32036038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Twelve-year delay of a nipple-sharing graft: A case report. 共用乳头移植延迟12年1例报告。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01 DOI: 10.1177/229255031302100310
Tatiana Ks Cypel, Mitchell Brown

The present report describes the use of a nipple-sharing technique for nipple areolar reconstruction using a donor nipple that was initially grafted from the contralateral and healthy breast 12 years earlier. There are many different techniques available to reconstruct the nipple. Although nipple sharing is not feasible to use in all patients, when available, it is an ideal approach for matching the contralateral nipple in terms of shape, colour, texture and long-term projection.

本报告描述了使用乳头共享技术进行乳头乳晕重建,该技术使用的供体乳头最初是12年前从对侧健康乳房移植的。有许多不同的技术可用于重建乳头。虽然乳头共用并不适用于所有患者,但在可行的情况下,它是在形状、颜色、质地和长期投影方面匹配对侧乳头的理想方法。
{"title":"Twelve-year delay of a nipple-sharing graft: A case report.","authors":"Tatiana Ks Cypel,&nbsp;Mitchell Brown","doi":"10.1177/229255031302100310","DOIUrl":"https://doi.org/10.1177/229255031302100310","url":null,"abstract":"<p><p>The present report describes the use of a nipple-sharing technique for nipple areolar reconstruction using a donor nipple that was initially grafted from the contralateral and healthy breast 12 years earlier. There are many different techniques available to reconstruct the nipple. Although nipple sharing is not feasible to use in all patients, when available, it is an ideal approach for matching the contralateral nipple in terms of shape, colour, texture and long-term projection. </p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/229255031302100310","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32027254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
You want me to write a business plan? Capital budgeting fundamentals for the plastic surgeon. 你想让我写一份商业计划?整形外科医生的基本资本预算。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01 DOI: 10.1177/229255031302100211
Douglas A McKay, Daniel A Peters
As we enter the new era of medicine in which cost becomes as important as outcomes, clinicians struggling to treat patients frequently find themselves in uncharted territory. Gone are the days in which a new technology or treatment will be embraced by hospital administrators simply because a surgeon makes a cogent argument that it will raise the quality of care delivered at the institution. Administrators want to know how much the intervention will cost, whether it is revenue positive or, at the very least, revenue neutral, and what the long-term implications will be on the global budget. Think of administrators as investors: they want to know if there is value in the investment. The yearly process of allocating funds in the hospital falls under the umbrella of capital budgeting. Regardless of whether we agree with the direction of things, there is certain advantage to being able to ‘talk the talk’. Understanding the calculations behind capital budgeting enables a clinician to do just that. Imagine, if you will, a struggling telecommunications company. Money is tight. Shareholders are demanding; they want return on investment. All decisions must be considered in the context of their ability to generate revenue. Managers need money to invest in projects in their respective departments. The engineers want money for research and development, the marketing division wants money for promotion and the HR department wants money for new hires. The CEO must decide what investments are most likely to generate revenue moving forward. To attract investment, departmental managers make arguments using a universal business tool: the business plan. They typically base their business plan on one of two capital budgeting calculations: net present value (NPV) or the internal rate of return (IRR). The hospital is no different, with one exception: the goal is savings, not profit. Treatments change rapidly when evidence emerges favouring one modality over another. The rapid integration of BRAF inhibitors into the melanoma treatment armamentarium is a good example. Costly interventions will emerge that drain funds; money saved can be re-allocated, enabling programs to evolve with the dynamism of treatment.
{"title":"You want me to write a business plan? Capital budgeting fundamentals for the plastic surgeon.","authors":"Douglas A McKay,&nbsp;Daniel A Peters","doi":"10.1177/229255031302100211","DOIUrl":"https://doi.org/10.1177/229255031302100211","url":null,"abstract":"As we enter the new era of medicine in which cost becomes as important as outcomes, clinicians struggling to treat patients frequently find themselves in uncharted territory. Gone are the days in which a new technology or treatment will be embraced by hospital administrators simply because a surgeon makes a cogent argument that it will raise the quality of care delivered at the institution. Administrators want to know how much the intervention will cost, whether it is revenue positive or, at the very least, revenue neutral, and what the long-term implications will be on the global budget. Think of administrators as investors: they want to know if there is value in the investment. The yearly process of allocating funds in the hospital falls under the umbrella of capital budgeting. Regardless of whether we agree with the direction of things, there is certain advantage to being able to ‘talk the talk’. Understanding the calculations behind capital budgeting enables a clinician to do just that. \u0000 \u0000Imagine, if you will, a struggling telecommunications company. Money is tight. Shareholders are demanding; they want return on investment. All decisions must be considered in the context of their ability to generate revenue. Managers need money to invest in projects in their respective departments. The engineers want money for research and development, the marketing division wants money for promotion and the HR department wants money for new hires. The CEO must decide what investments are most likely to generate revenue moving forward. To attract investment, departmental managers make arguments using a universal business tool: the business plan. They typically base their business plan on one of two capital budgeting calculations: net present value (NPV) or the internal rate of return (IRR). The hospital is no different, with one exception: the goal is savings, not profit. Treatments change rapidly when evidence emerges favouring one modality over another. The rapid integration of BRAF inhibitors into the melanoma treatment armamentarium is a good example. Costly interventions will emerge that drain funds; money saved can be re-allocated, enabling programs to evolve with the dynamism of treatment.","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/229255031302100211","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32034172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Recurrent ulnar nerve entrapment at the elbow: Correlation of surgical findings and 3-Tesla magnetic resonance neurography. 肘部复发尺神经卡压:手术表现与3-特斯拉磁共振神经造影的相关性。
IF 0.7 4区 医学 Q Medicine Pub Date : 2013-01-01 DOI: 10.1177/229255031302100305
Avneesh Chhabra, Vibhor Wadhwa, Rashmi S Thakkar, John A Carrino, A Lee Dellon

The authors describe the correlation between 3-Tesla magnetic resonance neurography (MRN) and surgical findings in two patients who underwent multiple previous failed ulnar nerve surgeries. MRN correctly localized the site of the abnormality. Prospectively observed MRN findings of perineural fibrosis, ulnar nerve re-entrapment abnormalities, medial antebrachial cutaneous neuroma and additional median nerve entrapment were confirmed surgically.

作者描述了3-特斯拉磁共振神经成像(MRN)与手术结果之间的相关性,这两例患者曾接受过多次失败的尺神经手术。MRN正确定位了异常部位。前瞻性MRN表现为神经周围纤维化、尺神经再夹持异常、前臂内侧皮神经瘤和额外正中神经夹持。
{"title":"Recurrent ulnar nerve entrapment at the elbow: Correlation of surgical findings and 3-Tesla magnetic resonance neurography.","authors":"Avneesh Chhabra,&nbsp;Vibhor Wadhwa,&nbsp;Rashmi S Thakkar,&nbsp;John A Carrino,&nbsp;A Lee Dellon","doi":"10.1177/229255031302100305","DOIUrl":"https://doi.org/10.1177/229255031302100305","url":null,"abstract":"<p><p>The authors describe the correlation between 3-Tesla magnetic resonance neurography (MRN) and surgical findings in two patients who underwent multiple previous failed ulnar nerve surgeries. MRN correctly localized the site of the abnormality. Prospectively observed MRN findings of perineural fibrosis, ulnar nerve re-entrapment abnormalities, medial antebrachial cutaneous neuroma and additional median nerve entrapment were confirmed surgically. </p>","PeriodicalId":50714,"journal":{"name":"Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":0.7,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/229255031302100305","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32027253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
期刊
Plastic Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1